date:May 23, 2014
28, 2014, versus $25,946,000 for the year ended February 28, 2013. Adjusted EBITDA was negative ($19,111,000) for the fiscal year, compared to negative ($5,946,000) in the prior year. Net loss was ($22,237,000) for the current year, versus a net loss of ($19,962,000) in the prior year.
The year-over-year decline in adjusted EBITDA, on both a nutraceutical and consolidated basis, is largely explained by lower gross margins resulting from the plant incident, higher legal fees due to intense nego